Condition: Alzheimers Disease · Sponsor: Hoffmann-La Roche
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
This description comes directly from the study's public registry record.
Reference Study ID Number: WP45722 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Banner Alzheimer?s Institute | Phoenix, Arizona, United States | Recruiting |
| Banner Sun Health Research Institute | Sun City, Arizona, United States | Recruiting |
| Sun Valley Research Center, Inc. | Imperial, California, United States | Recruiting |
| Inglewood Clinicals | Inglewood, California, United States | Recruiting |
| Irvine Center for Clinical Research | Irvine, California, United States | Recruiting |
| Healthy Brain Clinic | Long Beach, California, United States | Recruiting |
| Oakland Clinical | Oakland, California, United States | Recruiting |
| Riverside Clinical | Riverside, California, United States | Recruiting |
| Syrentis Clinical Research | Santa Ana, California, United States | Recruiting |
| Cenexel California Neuroscience Research, LLC | Sherman Oaks, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
+ 199 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07177352